Kantrex
Kantrex Brand names, Kantrex Analogs
Kantrex Brand Names Mixture
- No information avaliable
Kantrex Chemical_Formula
C18H36N4O11
Kantrex RX_link
http://www.rxlist.com/cgi/generic3/kanamycin.htm
Kantrex fda sheet
Kantrex msds (material safety sheet)
Kantrex Synthesis Reference
No information avaliable
Kantrex Molecular Weight
484.499 g/mol
Kantrex Melting Point
No information avaliable
Kantrex H2O Solubility
No information avaliable
Kantrex State
Solid
Kantrex LogP
-7.936
Kantrex Dosage Forms
No information avaliable
Kantrex Indication
For treatment of infections where one or more of the following are the known or suspected pathogens: E. coli, Proteus species (both indole-positive and indole-negative), E. aerogenes, K. pneumoniae, S. marcescens, and Acinetobacter species.
Kantrex Pharmacology
Kanamycin is an aminoglycoside antibiotic. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit, causing misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth. Aminoglycosides are useful primarily in infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, but other types of antibiotics are more potent and less damaging to the host. In the past the aminoglycosides have been used in conjunction with penicillin-related antibiotics in streptococcal infections for their synergistic effects, particularly in endocarditis. Aminoglycosides are mostly ineffective against anaerobic bacteria, fungi and viruses.
Kantrex Absorption
No information avaliable
Kantrex side effects and Toxicity
LD 50 - ORAL, MOUSE = 17500 MG/KG, LD 50 - ORAL, RAT = >4 GM/KG, LD 50 - ORAL, RABBIT = >3 GM/KG
Kantrex Patient Information
No information avaliable
Kantrex Organisms Affected
Enteric bacteria and other eubacteria
